Infliximab‐induced tuberculosis in patients with UC: Experience from India—a country with high prevalence of tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infliximab‐induced tuberculosis in patients with UC: Experience from India—a country with high prevalence of tuberculosis

Published:2017-05-30 Issue:6 Volume:32 Page:1191-1194
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Puri Amarender S¹,Desai Devendra²,Sood Ajit³,Sachdeva Sanjeev¹

Affiliation:

1. Department of GastroenterologyGB Pant Institute of Postgraduate Medical Education and Research New Delhi India

2. Department of GastroenterologyPD Hinduja Hospital Mumbai Mumbai India

3. Department of GastroenterologyDayanand Medical College Ludhiana India

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.13669

Reference11 articles.

1. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

2. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

3. Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden

4. Preventing Tuberculosis Flare in Patients with Inflammatory Rheumatic Diseases Receiving Tumor Necrosis Factor-α Inhibitors in India — An Audit Report

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening;Arab Journal of Gastroenterology;2024-02

2. Crohn’s Disease Among the Poorest Billion: Burden of Crohn’s Disease in Low- and Lower-Middle-Income Countries;Digestive Diseases and Sciences;2022-08-31

3. Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti‐TNF therapy in tuberculosis endemic region;Alimentary Pharmacology & Therapeutics;2022-03

4. Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study;Intestinal Research;2022-01-30

5. Tacrolimus as rescue therapy for steroid-dependent/steroid-refractory ulcerative colitis: Experience from tertiary referral center in India;Indian Journal of Gastroenterology;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3